Back to Search
JEFFREY LENNOX, M.D.
M.D.
Infectious Disease Physician
NPI: 1548376254Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
038844(GA)
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
The NEAT study: a 48-week open-label study to compare the antiviral efficacy and safety of GW433908 versus nelfinavir in antiretroviral therapy-naive HIV-1-infected patients.
PMID 14707788·J Acquir Immune Defic Syndr·2004
3-trial
Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study.
PMID 14699460·Clin Infect Dis·2004
3-trial
Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study.
PMID 10888979·Arch Intern Med·2000
8-other
Amprenavir: a new human immunodeficiency virus type 1 protease inhibitor.
PMID 10868554·Clin Ther·2000
6-review
Amprenavir: a review of its clinical potential in patients with HIV infection.
PMID 11152018·Drugs·2000
6-review
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel.
PMID 10647802·JAMA·2000
6-review
Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group.
PMID 11073755·Clin Infect Dis·2000
6-review
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.
PMID 19647866·Lancet·2009
3-trial
Antiretroviral therapy: when to start and which drugs to use.
PMID 18765108·Curr Infect Dis Rep·2008
8-other
Pharmacokinetics of an indinavir-ritonavir-fosamprenavir regimen in patients with human immunodeficiency virus.
PMID 18154477·Pharmacotherapy·2008
3-trial
Raltegravir with optimized background therapy for resistant HIV-1 infection.
PMID 18650512·N Engl J Med·2008
3-trial
Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.
PMID 18650513·N Engl J Med·2008
3-trial
Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection.
PMID 18667503·J Virol·2008
8-other
Liver enzymes elevation and immune reconstitution among treatment-naïve HIV-infected patients instituting antiretroviral therapy.
PMID 18004087·Am J Med Sci·2007
8-other
Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines.
PMID 17728221·J Virol·2007
8-other
Discovery of ANA975: an oral prodrug of the TLR-7 agonist isatoribine.
PMID 18066870·Nucleosides Nucleotides Nucleic Acids·2007
3-trial
Lopinavir/Ritonavir pharmacokinetic profile: impact of sex and other covariates following a change from twice-daily to once-daily therapy.
PMID 17615254·J Clin Pharmacol·2007
3-trial
Mucosal innate immune factors in the female genital tract are associated with vaginal HIV-1 shedding independent of plasma viral load.
PMID 16910835·AIDS Res Hum Retroviruses·2006
8-other
A dangerous dilemma: management of infectious intracranial aneurysms complicating endocarditis.
PMID 17067923·Lancet Infect Dis·2006
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 341 PONCE DE LEON AVE NE
ATLANTA, GA 30308 - Phone
- (404) 616-2493
Quick Facts
- NPI
- 1548376254
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile